Citigroup Inc Gilead Sciences, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 2,352,888 shares of GILD stock, worth $231 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,352,888

Previous 2,479,687 5.11%

Holding current value

$231 Million

Previous $170 Million 15.92%

% of portfolio

0.12%

Previous 0.11%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $8.44 Million - $10.6 Million	-126,799 Reduced 5.11%	2,352,888 $197 Million
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $64.4 Million - $74.3 Million	1,019,158 Added 69.78%	2,479,687 $170 Million
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $17.8 Million - $21.7 Million	-248,910 Reduced 14.56%	1,460,529 $107 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $19.9 Million - $22.5 Million	-270,960 Reduced 13.68%	1,709,439 $138 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $6.69 Million - $7.3 Million	-90,454 Reduced 4.37%	1,980,399 $148 Million
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $12 Million - $13.7 Million	157,496 Added 8.23%	2,070,853 $160 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $5.31 Million - $6.05 Million	68,737 Added 3.73%	1,913,357 $159 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $5.24 Million - $7.52 Million	-84,044 Reduced 4.36%	1,844,620 $158 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $9.92 Million - $11.3 Million	166,557 Added 9.45%	1,928,664 $119 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $25.3 Million - $28.5 Million	-439,080 Reduced 19.95%	1,762,107 $109 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $2.45 Million - $3.08 Million	42,378 Added 1.96%	2,201,187 $131 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $46 Million - $52.2 Million	709,059 Added 48.91%	2,158,809 $157 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $98.1 Million - $106 Million	1,449,750 New	1,449,750 $101 Million

Others Institutions Holding GILD

# of Institutions

1,962

Shares Held

995M

Call Options Held

10.5M

Put Options Held

9.85M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $123B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account